RESPIVax™ 5 + PH-M, a convenient, single dose vaccine to protect cattle against viral and bacteria challenges associated with Bovine Respiratory Disease (BRD), is now available from Huvepharma.
The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 (monensin Type A medicated article) from global animal health company Huvepharma® – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.
October 1, 2018 (Peachtree City, GA) – Huvepharma®, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the release of a conditional licensed vaccine for the prevention of pinkeye caused by Moraxella bovoculi in cattle.
August 28, 2018 (Peachtree City, GA) – Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.